CoChat

Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial

Open access
Cai, Hua, Qin, Yue-Lan, Shi, Ze-Ya, Chen, Jin-Hui, Zeng, Min-Jie, Zhou, Wei, Chen, Ru-Qun, Chen, Zhi-Yuan · 2019 · BMC Gastroenterology

Published version of a preprint

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Background: Alternate-day fasting (ADF) is a novel diet therapy that may achieve reduction in body weight and improvement of dyslipidaemia, but the impact of this diet on patients with non-alcoholic fatty liver disease (NAFLD) remains unknown. The aim of this study was to evaluate the effects of ADF on the body weight and lipid profile of individuals with NAFLD. Methods: NAFLD patients ( n = 271) were randomised to the ADF group, time-restricted feeding (TRF) group, or the control group and subjected to the respective diet for 12 weeks. Anthropometric measurements (body weight, fat mass/fat-free mass) were performed, and plasma lipids were analysed enzymatically. Results: Within 4 weeks, the body weight decreased significantly ( P < 0.001) in the ADF group by 4.56 ± 0.41 kg (6.1 ± 0.5%) and the TRF group by 3.62 ± 0.65 kg (4.83 ± 0.9%) compared to the control group, and it decreased even more after 12 weeks in both groups (ADF: − 4.04 ± 0.54 kg, 5.4 ± 0.7%; TRF: − 3.25 ± 0.67 kg, 4.3 ± 0.9%). Fat mass was significantly reduced by ADF (− 3.49 ± 0.37 kg; 11 ± 1.2%) and TRF (− 2.91 ± 0.41 kg; 9.6 ± 1.3%), with ADF leading to a further reduction in fat mass after 12 weeks (− 3.48 ± 0.38 kg; 11 ± 1.2%). Total cholesterol was significantly decreased at both time points in the ADF group (− 0.91 ± 0.07 mmol/L; 18.5 ± 1.5%) compared to the control and TRF groups. Both ADF (− 0.64 ± 0.06 mmol/L; 25 ± 1.9%) and TRF (0.58 ± 0.07 mmol/L; 20 ± 1.7%) achieved a significant reduction in serum triglycerides ( P < 0.001) after 12 weeks. Changes in fat free mass, HDL, LDL, fasting insulin, glucose, liver stiffness, and systolic or diastolic blood pressure did not differ between the groups. Conclusions: ADF appears to be an effective diet therapy for individuals with NAFLD that can achieve weight loss and improvement of dyslipidaemia within a relatively short period of time (4 to 12 weeks). Potential preventive effects of ADF on cardiovascular disease need to be confirmed by future investigations. Trial registration: ChiCTR1900024411 , this trial was retrospectively registered on July 10, 2019.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12876-019-1132-8

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow chart of the study protocol. ADF: alternate-day fasting; TRF: time-restricted feeding
Fig. 1 Flow chart of the study protocol. ADF: alternate-day fasting; TRF: time-restricted feedingCC BY · PubMed Central
Fig. 2 Changes in body weight and body composition at week 4 and week 12. Values are reported as mean ± standard deviation. ADF: alternate-day fasting; TRF: time-restricted feeding. Significant decreases in body weight and fat mass were observed in the ADF and TRF groups compared to the control group. : P < 0.001; : P < 0.05
Fig. 2 Changes in body weight and body composition at week 4 and week 12. Values are reported as mean ± standard deviation. ADF: alternate-day fasting; TRF: time-restricted feeding. Significant decreases in body weight and fat mass were observed in the ADF and TRF groups compared to the control group. : P < 0.001; : P < 0.05CC BY · PubMed Central
Fig. 3 Changes in dyslipidaemia at week 4 and week 12. Values are reported as mean ± SEM (standard error of the mean) ADF achieved a significant decrease in total cholesterol compared to both the control and TRF groups. Triglycerides were significantly decreased in both the ADF and TRF groups compared to the control group. : P < 0.001; : P < 0.05.
Fig. 3 Changes in dyslipidaemia at week 4 and week 12. Values are reported as mean ± SEM (standard error of the mean) ADF achieved a significant decrease in total cholesterol compared to both the control and TRF groups. Triglycerides were significantly decreased in both the ADF and TRF groups compared to the control group. : P < 0.001; : P < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 223

Metadata

Authors
Cai, H., Qin, Y.-L., Shi, Z.-Y., Chen, J.-H., Zeng, M.-J., Zhou, W., Chen, R.-Q., & Chen, Z.-Y.
Affiliations
Hunan Provincial People's Hospital (CN)
Venue
BMC Gastroenterology
Published
2019-12
Volume
19
Issue
1
Pages
219-219
ISSN
1471-230X (ISSN-L)
OpenAlex
W2994761268
Cited by
205
References
31
Citations by year
2026: 11 · 2025: 31 · 2024: 43 · 2023: 38 · 2022: 40 · 2021: 23 · 2020: 16 · 2019: 1
FWCI
13.72
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Gastroenterology (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords
alternate-day fasting, non-alcoholic fatty liver disease, time-restricted feeding, weight loss, fat mass, dyslipidemia, plasma lipids, triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol, dietary intervention, obesity, fat-free mass index, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase
MeSH terms
Adult, Body Composition, Body Weight, Energy Intake, Cholesterol, Fasting, Feeding Behavior, Female, Humans, Hunger, Male, Metabolic Diseases, Risk Factors, Time Factors, Triglycerides, Weight Loss, Outcome Assessment, Health Care, Adiposity, Dyslipidemias, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. https://app.cochat.ai/papers/10.1186/s12876-019-1132-8
The paper
Cai, H., Qin, Y.-L., Shi, Z.-Y., Chen, J.-H., Zeng, M.-J., Zhou, W., Chen, R.-Q., & Chen, Z.-Y. (2019). Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. BMC Gastroenterology. https://doi.org/10.1186/s12876-019-1132-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.